Bharat Biotech International Limited (BBIL) has welcomed Prime Minister Narendra Modi’s gesture for taking the first dose of its covid vaccine, Covaxin.
Thanking the Prime Minister, Krishna Ella, Chairman & Managing Director, Bharat Biotech, said: “This has set a powerful example for all Indians to follow, which will go a long way in reducing vaccine hesitancy and building confidence in immunization against the ongoing pandemic.”
He also thanked Modi for reposing his trust in the indigenously developed Covaxin.
Covaxin contains a whole virion inactivated SARS-CoV-2 vaccine produced in Vero cells, the Hyderabad-based company said in a release.